About this trial
This project is a case-control study which seeks to identify modifiable risk factors for breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete a risk factor questionnaire which contains information about their diet, physical activity, past medical history and life style factors. They will also be required to provide information on their body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water percentage.
Based on the existing ARGO platform where a current colorectal cancer study is going on, approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into this study. Comparatively, we will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Based on the existing African Research Group for Oncology platform where a current colorectal study is going on, 400 patients with a prior diagnosis and a new diagnosis of colorectal cancer or breast cancer will be recruited into this study. A combined total of 400 controls will be recruited from community mobilization groups and the Outpatient Health Center at OAU who are free of cancer and gastrointestinal diseases.
Trial design
Case-control
Prospective
Treatments tested in this trial
Questionnaire
BehavioralQuestionnaire containing questions regarding diet, physical activity, past medical history and life style practices.
Bioimpedance/Body Composition Unit
DevicePatients will provide information on body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water.
Treatment groups
Trial outcomes
Primary outcomes
Development and Validation of Questionnaire For Assessing Modifiable Risk Factors for Cancer in Sub-Saharan Africa
Determination of Novel Modifiable Cancer Risk Factors in a Nigerian Population
We will determine the presence of established, plausible, and novel cancer risk factors in cases (n=400) and controls (n=400) in Nigeria
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Obafemi Awolowo University Teaching Hospital
Lead sponsor
Memorial Sloan Kettering Cancer Center
Collaborator
Lagos State University
Collaborator
University of Ilorin Teaching Hospital
Collaborator
Federal Medical Centre, Owo
Collaborator
University of Maiduguri Teaching Hospital
Collaborator
National Hospital, Abuja
Collaborator